Clinical Trial: HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712705) titled 'HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.' on July 07.

Brief Summary: The goal of this clinical trial is to learn if drug HPP737 works to treat moderate-to-severe plaque psoriasis in adults. It will also learn about the safety of drug HPP737. The main questions it aims to answer are:

Does drug HPP737 improve psoriasis severity compared to a placebo at Week 16, as measured by the proportion of patients achieving a significant reduction in the Psoriasis Area and Severity Index (PASI) score? What medical problems do participants have when taking drug HPP737? Researchers will compare drug HPP737 to a placebo (a...